The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function

Clinical trial NCT06587386 · COMPLETED

Trial details

NCT number: NCT06587386
Sponsor: Affiliated Hospital of Jiaxing University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Motion Sickness

Start date: 2025-05-20
Primary completion: 2025-11-10
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.